Cizzle Biotechnology Holdings Plc
LSE:CIZ.L
Sector
Location
Market Cap
USD 8.11 M
Share Price
USD 0.02
Avg Daily Volume
1,415,569
Change (1 day)
0.19%
Change (1 year)
-15.85%
Change (YTD)
5.98%
Cizzle Biotechnology Holdings Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023: USD 1.24 K
Cizzle Biotechnology Holdings Plc Selling, General, and Administrative Expenses (SG&A) is USD 1.24 K for the year ending December 31, 2023, a -99.73% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Cizzle Biotechnology Holdings Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 460.47 K, a 27.92% change year over year.
-
Cizzle Biotechnology Holdings Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 359.96 K, a 15.10% change year over year.
-
Cizzle Biotechnology Holdings Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 312.72 K.
StockViz
Competitors
Roche Holding AG
USD 340.96
RO.SW
+1.66
0.49%
Thermo Fisher Scientific Inc.
USD 499.99
TMO
+16.23
3.36%
Boston Scientific Corporation
USD 106.17
BSX
+0.96
0.91%
Becton, Dickinson and Company
USD 199.66
BDX
+3.03
1.54%
Fresenius SE & Co. KGaA
USD 55.90
FRE.DE
+0.69
1.25%
Sartorius Stedim Biotech S.A.
USD 208.47
DIM.PA
+3.85
1.88%
bioMérieux S.A.
USD 149.34
BIM.PA
+1.47
1.00%
United Therapeutics Corporation
USD 312.23
UTHR
+1.57
0.51%
Medpace Holdings, Inc.
USD 463.64
MEDP
+10.30
2.27%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.37
603392.SS
+0.39
4.91%
Revvity, Inc.
USD 94.15
RVTY
+4.48
5.00%
Exact Sciences Corporation
USD 47.47
EXAS
+0.79
1.69%
Bio-Techne Corporation
USD 57.09
TECH
+3.09
5.72%
Sysmex Corporation
USD 13.38
6869.T
+0.15
1.16%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 7.36
002294.SZ
+0.22
3.06%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
Roche Holding AG
USD 340.96
RO.SW
+1.66
0.49%
Thermo Fisher Scientific Inc.
USD 499.99
TMO
+16.23
3.36%
Boston Scientific Corporation
USD 106.17
BSX
+0.96
0.91%
Becton, Dickinson and Company
USD 199.66
BDX
+3.03
1.54%
Fresenius SE & Co. KGaA
USD 55.90
FRE.DE
+0.69
1.25%
Sartorius Stedim Biotech S.A.
USD 208.47
DIM.PA
+3.85
1.88%
bioMérieux S.A.
USD 149.34
BIM.PA
+1.47
1.00%
United Therapeutics Corporation
USD 312.23
UTHR
+1.57
0.51%
Medpace Holdings, Inc.
USD 463.64
MEDP
+10.30
2.27%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.37
603392.SS
+0.39
4.91%
Revvity, Inc.
USD 94.15
RVTY
+4.48
5.00%
Exact Sciences Corporation
USD 47.47
EXAS
+0.79
1.69%
Bio-Techne Corporation
USD 57.09
TECH
+3.09
5.72%
Sysmex Corporation
USD 13.38
6869.T
+0.15
1.16%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 7.36
002294.SZ
+0.22
3.06%